Study on the Evaluation of Lung Cancer Patients from the Three Aspects of Emotion

Table 5

Comparison of the QoL between those who have not progressed and those who have progressed after chemotherapy.

QoL dimension	Pre-chemotherapy score (n = 219)	Post-chemotherapy (disease has not progressed) (n = 175)	T1 value	Post-chemotherapy (disease progression) (n = 44)	T2 value
Functional dimension	68.44 ± 16.28	63.52 ± 19.43	2.61	47.36 ± 23.09	4.52
Overall QoL	56.28 ± 21.32	54.49 ± 19.06	0.827	40.06 ± 20.66	4.30
Symptom dimension	27.73 ± 15.26	33.72 ± 17.94	−3.83	44.34 ± 18.28	−3.50
Lung cancer symptoms	22.31 ± 13.86	22.23 ± 9.37	0.05	30.95 ± 18.47	−2.83
Related side effects	9.44 ± 8.05	19.52 ± 13.15	−6.69	31.18 ± 22.43	−3.46